Full View

Rational design of hybrid SARS-CoV-2 main protease inhibitors guided by the superimposed cocrystal structures with the peptidomimetic inhibitors GC-376, telaprevir …

Z Xia, M Sacco, Y Hu, C Ma, X Meng… - ACS pharmacology & …, 2021 - ACS Publications
SARS-CoV-2 main protease (Mpro) is a cysteine protease that mediates the cleavage of
viral polyproteins and is a validated antiviral drug target. Mpro is highly conserved among all …
被引用次数：76 相关文章

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376 …

Z Xia, M Sacco, Y Hu, C Ma, X Meng… - ACS Pharmacology …, 2021 - scholars.uthscsa.edu
Abstract SARS-CoV-2 main protease (Mpro) is a cysteine protease that mediates the
cleavage of viral polyproteins and is a validated antiviral drug target. Mpro is highly …

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376 …

Z Xia, M Sacco, Y Hu, C Ma, X Meng… - ACS Pharmacology & …, 2021 - europepmc.org
SARS-CoV-2 main protease (M pro) is a cysteine protease that mediates the cleavage of
viral polyproteins and is a validated antiviral drug target. M pro is highly conserved among …

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376 …

Z Xia, M Sacco, Y Hu, C Ma, X Meng… - ACS …, 2021 - researchwithrutgers.com
Abstract SARS-CoV-2 main protease (Mpro) is a cysteine protease that mediates the
cleavage of viral polyproteins and is a validated antiviral drug target. Mpro is highly …

[引用][C] Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376 …

Z Xia, M Sacco, Y Hu, C Ma, X Meng, F Zhang… - ACS Pharmacology & …, 2021 - cir.nii.ac.jp
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed
Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir …

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376 …

Z Xia, M Sacco, Y Hu, C Ma, X Meng… - ACS …, 2021 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 main protease (M pro) is a cysteine protease that mediates the cleavage of
viral polyproteins and is a validated antiviral drug target. M pro is highly conserved among …
[HTML] nih.gov

[HTML][HTML] Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376 …

Z Xia, M Sacco, Y Hu, C Ma, X Meng… - ACS Pharmacology & …, 2021 - ncbi.nlm.nih.gov
SARS-CoV-2 main protease (Mpro) is a cysteine protease that mediates the cleavage of
viral polyproteins and is a validated antiviral drug target. Mpro is highly conserved among all …

[引用][C] Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal S

Z Xia, M Sacco, Y Hu, C Ma, X Meng, F Zhang… - ACS Pharmacol. Transl …, 2021 - osti.gov

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376 …

Z Xia, M Sacco, Y Hu, C Ma, X Meng… - ACS Pharmacology & …, 2021 - europepmc.org
SARS-CoV-2 main protease (Mpro) is a cysteine protease that mediates the cleavage of
viral polyproteins and is a validated antiviral drug target. Mpro is highly conserved among all …

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376 …

Z Xia, M Sacco, Y Hu, C Ma, X Meng… - ACS …, 2021 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 main protease (M pro) is a cysteine protease that mediates the cleavage of
viral polyproteins and is a validated antiviral drug target. M pro is highly conserved among …